Literature DB >> 22136326

Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity.

Faiyaz Ahmed1, Asna Urooj.   

Abstract

CONTEXT: Ficus racemosa Linn. (Moraceae) bark is a rich source of phenolic compounds having diverse biological properties including antioxidant activity. The present study evaluated the cardioprotective activity of sequential acetone extract of Ficus racemosa bark against doxorubicin-induced cardiotoxicity in rats.
MATERIALS AND METHODS: The extract was standardized by high-performance liquid chromatography (HPLC) and subjected to acute toxicological evaluation in mice. Cardiotoxicity was induced by administration of doxorubicin (10 mg kg(-1) i.v.) to the extract pretreated rats (250 and 500 mg kg(-1)) and compared with that of Arjuna, a standard cardiotonic. Biochemical parameters included CK-MB, LDH, AST, ALT, troponin I, thiobarbituric acid reactive substances (TBARS), and glutathione.
RESULTS: The HPLC fingerprinting of the extract indicated the presence of bergenin (0.89%) and bergapten (0.07%). In an acute toxicity study, the extract at a dose of 2 g kg(-1) did not cause any adverse changes and no mortality was observed. Administration of doxorubicin significantly increased (p ≤ 0.05) serum levels of creatine kinase, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase, which were decreased to an extent of 68, 63, 41, and 65%, respectively, in extract pretreated group (500 mg kg(-1)). Troponin I was undetected in control group, while it was found in serum of all the experimental groups. The extract pretreatment significantly decreased (p ≤ 0.05) TBARS and increased glutathione levels in serum and cardiac tissue. These observations were further substantiated by the histopathological studies.
CONCLUSION: The acetone extract of F. racemosa bark possesses potential cardioprotective activity against doxorubicin-induced cardiotoxicity in rats by scavenging free radicals generated by the administration of the drug.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136326     DOI: 10.3109/13880209.2011.613848

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  3 in total

1.  Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism.

Authors:  Fang Zhou; Gang Hao; Jingwei Zhang; Yuanting Zheng; Xiaolan Wu; Kun Hao; Fang Niu; Dan Luo; Yuan Sun; Liang Wu; Wencai Ye; Guangji Wang
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes.

Authors:  Gang Dong; Yun Zhou; Xiaoli Song
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

3.  Protective effects of Ficus racemosa stem bark against doxorubucin-induced renal and testicular toxicity.

Authors:  Faiyaz Ahmed; Asna Urooj; Alias A Karim
Journal:  Pharmacogn Mag       Date:  2013-04       Impact factor: 1.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.